SCHRODER INVESTMENT MANAGEMENT GROUP - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 83 filers reported holding FLEXION THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 2.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$14,778,000
+129.8%
1,280,626
+101.7%
0.01%0.0%
Q3 2020$6,432,000
-21.2%
634,991
+2.3%
0.01%
-33.3%
Q2 2020$8,164,000
+66.5%
620,864
-1.9%
0.02%
+50.0%
Q1 2020$4,904,000
-61.2%
632,823
+3.7%
0.01%
-52.4%
Q4 2019$12,631,000
+58.5%
610,190
+6.5%
0.02%
+50.0%
Q3 2019$7,968,000
+13.9%
572,808
+0.7%
0.01%
+7.7%
Q2 2019$6,997,000
+12.5%
568,876
+14.1%
0.01%
+18.2%
Q1 2019$6,220,000
-1.2%
498,408
-10.4%
0.01%0.0%
Q4 2018$6,298,000
-30.7%
556,351
+14.5%
0.01%
-31.2%
Q3 2018$9,088,000
-28.3%
485,730
-3.3%
0.02%
-27.3%
Q2 2018$12,669,000
+10.3%
502,342
-2.0%
0.02%
+10.0%
Q1 2018$11,485,000
-11.3%
512,477
-0.9%
0.02%
-4.8%
Q4 2017$12,945,000
+26.8%
516,981
+21.0%
0.02%
+16.7%
Q3 2017$10,205,000
-2.6%
427,175
-16.1%
0.02%
-5.3%
Q2 2017$10,474,000
-50.9%
509,427
-35.4%
0.02%0.0%
Q1 2017$21,340,000
+89.9%
788,028
+33.4%
0.02%
-13.6%
Q4 2016$11,237,000
+73.5%
590,778
+78.2%
0.02%
+83.3%
Q3 2016$6,478,000
+30.6%
331,5300.0%0.01%
+20.0%
Q2 2016$4,961,000
+66.3%
331,5300.0%0.01%
+66.7%
Q1 2016$2,984,000
-67.1%
331,530
-29.5%
0.01%
-68.4%
Q4 2015$9,061,000
+56.9%
470,200
+21.0%
0.02%
+58.3%
Q3 2015$5,776,000
-24.1%
388,700
+6.3%
0.01%
-20.0%
Q2 2015$7,607,000
+28.3%
365,700
+38.1%
0.02%
+25.0%
Q1 2015$5,928,000
+12.9%
264,900
+1.9%
0.01%
+20.0%
Q4 2014$5,249,000260,0000.01%
Other shareholders

There were no reported owners of FLEXION THERAPEUTICS INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of FLEXION THERAPEUTICS INC shareholders